$SHMP
NaturalShrimp Inc Stock $shmp

$shmp Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-Q Financial Statement

#000149315224006697 Filed on February 14, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2022 Q4
Revenue	$81.12K	$101.3K	$97.94K
YoY Change	53.99%	3.43%	488.6%
Cost Of Revenue	$1.600K	$23.35K
YoY Change	-99.2%
Gross Profit	$79.52K	$77.95K	$97.94K
YoY Change	-153.67%	-20.41%
Gross Profit Margin	98.03%	76.95%	100.0%
Selling, General & Admin	$1.885M	$1.551M	$2.356M
YoY Change	7.44%	-34.19%	22.33%
% of Gross Profit	2370.2%	1989.43%	2405.88%
Research & Development	$0.00		$14.21K
YoY Change			-30.19%
% of Gross Profit	0.0%		14.51%
Depreciation & Amortization	$800.6K	$433.0K	$416.0K
YoY Change	-1.54%	4.09%	90.71%
% of Gross Profit	1006.79%	555.49%	424.74%
Operating Expenses	$2.684M	$2.351M	$3.154M
YoY Change	6.46%	-25.46%	24.57%
Operating Profit	-$2.604M	-$2.273M	-$3.057M
YoY Change	-2.43%	-25.62%	21.51%
Interest Expense	-$2.737M	-$3.141M	$15.86M
YoY Change	108.11%	-119.81%	19476.76%
% of Operating Profit
Other Income/Expense, Net		-$3.129M	$18.23M
YoY Change		-117.16%	-159.1%
Pretax Income	-$5.255M	-$5.402M	$15.18M
YoY Change	18.49%	-135.6%	-145.48%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$5.437M	-$5.402M	$15.18M
YoY Change	20.95%	-135.6%	-145.48%
Net Earnings / Revenue	-6702.53%	-5332.63%	15494.42%
Basic Earnings Per Share		-$0.01	$0.02
Diluted Earnings Per Share	-$0.01	-$0.01	$0.01
COMMON SHARES
Basic Shares Outstanding	1.044B shares	924.0M shares	751.4M shares
Diluted Shares Outstanding		938.2M shares	1.629B shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$115.5K	$36.32K	$141.9K
YoY Change	-46.63%	-74.4%	-94.68%
Cash & Equivalents	$115.5K	$36.32K	$141.9K
Short-Term Investments
Other Short-Term Assets	$169.7K	$242.6K	$617.1K
YoY Change	-89.55%	-60.68%	-88.41%
Inventory	$68.51K	$38.67K	$101.9K
Prepaid Expenses	$169.7K	$242.6K	$490.1K
Receivables	$27.45K	$16.32K	$7.502K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$381.1K	$333.9K	$868.4K
YoY Change	-79.75%	-61.55%	-89.17%
LONG-TERM ASSETS
Property, Plant & Equipment	$13.30M	$13.76M	$15.35M
YoY Change	-11.58%	-10.34%	11.51%
Goodwill
YoY Change
Intangibles	$5.879M	$5.976M
YoY Change	-6.22%
Long-Term Investments
YoY Change
Other Assets	$14.03M	$14.36M	$16.07M
YoY Change	-10.38%	-10.61%	-19.16%
Total Long-Term Assets	$27.34M	$28.13M	$31.42M
YoY Change	-10.97%	-10.48%	-6.61%
TOTAL ASSETS
Total Short-Term Assets	$381.1K	$333.9K	$868.4K
Total Long-Term Assets	$27.34M	$28.13M	$31.42M
Total Assets	$27.72M	$28.46M	$32.29M
YoY Change	-14.94%	-11.85%	-22.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$3.496M	$3.679M	$3.523M
YoY Change	-0.41%	4.42%	6.08%
Accrued Expenses	$3.250M	$2.564M	$300.0K
YoY Change	147.19%	754.89%	-40.06%
Deferred Revenue		$25.00K
YoY Change
Short-Term Debt	$900.2K	$900.2K	$765.2K
YoY Change	18.42%	17.64%	48.46%
Long-Term Debt Due	$30.31M	$3.074M	$2.315M
YoY Change	887.05%	32.75%	2311.82%
Total Short-Term Liabilities	$38.53M	$10.74M	$9.060M
YoY Change	243.34%	18.55%	-62.8%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$24.70M	$20.27M
YoY Change	-100.0%	21.85%	4091.61%
Other Long-Term Liabilities	$43.33K	$5.590K	$231.7K
YoY Change	-65.39%	-97.59%	-23.76%
Total Long-Term Liabilities	$43.33K	$24.71M	$20.50M
YoY Change	-99.8%	20.5%	2503.41%
TOTAL LIABILITIES
Total Short-Term Liabilities	$38.53M	$10.74M	$9.060M
Total Long-Term Liabilities	$43.33K	$24.71M	$20.50M
Total Liabilities	$38.57M	$35.45M	$29.56M
YoY Change	18.1%	19.9%	17.59%
SHAREHOLDERS EQUITY
Retained Earnings	-$183.8M	-$178.4M	-$163.0M
YoY Change	9.7%	9.44%	60.16%
Common Stock	$111.7K	$99.56K	$76.89K
YoY Change	38.99%	29.48%	19.8%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$56.88M	-$52.66M	-$42.89M
YoY Change
Total Liabilities & Shareholders Equity	$27.72M	$28.46M	$32.29M
YoY Change	-14.94%	-11.85%	-22.5%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2022 Q4
OPERATING ACTIVITIES
Net Income	-$5.437M	-$5.402M	$15.18M
YoY Change	20.95%	-135.6%	-145.48%
Depreciation, Depletion And Amortization	$800.6K	$433.0K	$416.0K
YoY Change	-1.54%	4.09%	90.71%
Cash From Operating Activities	-$1.017M	-$657.4K	-$254.3K
YoY Change	-48.46%	158.53%	-96.84%
INVESTING ACTIVITIES
Capital Expenditures	-$25.13K	$18.84K	$2.221M
YoY Change	-121.25%	-99.15%	-466.56%
Acquisitions
YoY Change
Other Investing Activities	$105.0K	$0.00	$700.0K
YoY Change		-100.0%
Cash From Investing Activities	$130.1K	-$18.84K	-$1.521M
YoY Change	-210.04%	-98.76%	151.05%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	966.4K	665.4K	1.356M
YoY Change	-55.4%	-50.93%	-87.11%
NET CHANGE
Cash From Operating Activities	-1.017M	-657.4K	-254.3K
Cash From Investing Activities	130.1K	-18.84K	-1.521M
Cash From Financing Activities	966.4K	665.4K	1.356M
Net Change In Cash	79.21K	-10.77K	-419.6K
YoY Change	6.18%	-97.43%	-122.5%
FREE CASH FLOW
Cash From Operating Activities	-$1.017M	-$657.4K	-$254.3K
Capital Expenditures	-$25.13K	$18.84K	$2.221M
Free Cash Flow	-$992.2K	-$676.2K	-$2.476M
YoY Change	-52.57%	-72.69%	-66.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent		usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Central Index Key EntityCentralIndexKey	0001465470
CY2023Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2023Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold		usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2023Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization		usd
CY2023Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
CY2023Q4	us-gaap	Loss From Catastrophes LossFromCatastrophes		usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes		usd
CY2023Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt		usd
CY2022Q4	SHMP	Extension Fee ExtensionFee		usd
	SHMP	Extension Fee ExtensionFee		usd
CY2022Q4	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
CY2023Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2022Q4	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
CY2023Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares		usd
CY2023Q2	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q2	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature		usd
CY2022Q2	SHMP	Common Stock Issued In Business Agreement To Be Paid From Revenue Earned CommonStockIssuedInBusinessAgreementToBePaidFromRevenueEarned		usd
CY2022Q3	SHMP	Common Stock Issued For Legal Settlement To Nsh Shareholders CommonStockIssuedForLegalSettlementToNshShareholders		usd
CY2022Q3	SHMP	Common Stock Issued From Shares Payable CommonStockIssuedFromSharesPayable		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax		usd
	SHMP	Extension Fees ExtensionFees		usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts		usd
	SHMP	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt		usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment		usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense		usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease		usd
	SHMP	Loss Due To Fire LossDueToFire		usd
	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties		usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability		usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit		usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable		usd
	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt		usd
	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture		usd
	SHMP	Proceeds From Sale Of Preferred Stock ProceedsFromSaleOfPreferredStock		usd
	SHMP	Proceeds From Sale Of Preferred Stock Series G ProceedsFromSaleOfPreferredStockSeriesG		usd
	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets		usd
	SHMP	Dividends On Series E Preferred Stock DividendsOnSeriesEPreferredStock		usd
	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind		usd
	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement		usd
CY2022Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue		usd
CY2023	SHMP	Reclass Of Accrued Interest ReclassOfAccruedInterest		usd
	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	000-54030
	dei	Entity Registrant Name EntityRegistrantName	NATURALSHRIMP INCORPORATED
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	74-3262176
	dei	Entity Address Address Line1 EntityAddressAddressLine1	13601 Preston Road
	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite E1092
	dei	Entity Address City Or Town EntityAddressCityOrTown	Dallas
	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	75240
	dei	City Area Code CityAreaCode	(888)
	dei	Local Phone Number LocalPhoneNumber	791-9474
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	1044421186	shares
CY2023Q4	us-gaap	Cash Cash	36315	usd
CY2023Q1	us-gaap	Cash Cash	216465	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16321	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17325	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	38669	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	25725	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	242632	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	286593	usd
CY2023Q1	us-gaap	Deferred Offering Costs DeferredOfferingCosts	1336263	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	333937	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	1882371	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13763637	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15043715	usd
CY2023Q4	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	25130	usd
CY2023Q1	us-gaap	Inventory Real Estate Construction In Process InventoryRealEstateConstructionInProcess	25130	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	5976000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	6268500	usd
CY2023Q4	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	8332376	usd
CY2023Q1	SHMP	Indefinite Lived Intangible Assets IndefiniteLivedIntangibleAssets	9142376	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	9394	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	204243	usd
CY2023Q4	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2023Q1	us-gaap	Deposits Assets DepositsAssets	20633	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14363533	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	15660882	usd
CY2023Q4	us-gaap	Assets Assets	28461107	usd
CY2023Q1	us-gaap	Assets Assets	32586968	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	3679009	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3510206	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1295246	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1314961	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	25000	usd
CY2023Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2023Q1	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	19817	usd
CY2023Q4	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2410000	usd
CY2023Q1	SHMP	Restructured August Note Payable RestructuredAugustNotePayable	2400000	usd
CY2023Q4	us-gaap	Dividends Payable Current DividendsPayableCurrent	479304	usd
CY2023Q1	us-gaap	Dividends Payable Current DividendsPayableCurrent	579248	usd
CY2023Q4	SHMP	Warrant Liability WarrantLiability	17950	usd
CY2023Q1	SHMP	Warrant Liability WarrantLiability	355000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3804	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	87804	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10739683	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	11221783	usd
CY2023Q4	us-gaap	Senior Notes SeniorNotes	24700000	usd
CY2023Q1	us-gaap	Senior Notes SeniorNotes	21290000	usd
CY2023Q1	us-gaap	Long Term Notes Payable LongTermNotesPayable	23604	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5590	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	125189	usd
CY2023Q4	us-gaap	Liabilities Liabilities	35445273	usd
CY2023Q1	us-gaap	Liabilities Liabilities	32660576	usd
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2023Q1	us-gaap	Preferred Stock Value PreferredStockValue	500	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	994965427	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	994965427	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	803123748	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	803123748	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	99560	usd
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	80377	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	125327383	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178425983	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	121156733	usd
CY2023Q4	SHMP	Stock To Be Issued StockToBeIssued	-390024	usd
CY2023Q1	SHMP	Stock To Be Issued StockToBeIssued	-662767	usd
CY2023Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2023Q1	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	56250	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-167533292	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-52664766	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-45689165	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28461107	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32586968	usd
CY2023Q4	us-gaap	Revenues Revenues	101302	usd
CY2022Q4	us-gaap	Revenues Revenues	97943	usd
	us-gaap	Revenues Revenues	365184	usd
	us-gaap	Revenues Revenues	186004	usd
CY2023Q4	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	23353	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	124094	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	77949	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	97943	usd
	us-gaap	Gross Profit GrossProfit	241090	usd
	us-gaap	Gross Profit GrossProfit	186004	usd
CY2023Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1473637	usd
CY2022Q4	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1481195	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5175980	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4256819	usd
CY2022Q4	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	14212	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	190855	usd
CY2023Q4	SHMP	Facility Operations FacilityOperations	77103	usd
CY2022Q4	SHMP	Facility Operations FacilityOperations	875194	usd
	SHMP	Facility Operations FacilityOperations	592878	usd
	SHMP	Facility Operations FacilityOperations	1895357	usd
CY2023Q4	us-gaap	Depreciation Depreciation	433053	usd
CY2022Q4	us-gaap	Depreciation Depreciation	416377	usd
	us-gaap	Depreciation Depreciation	1304732	usd
	us-gaap	Depreciation Depreciation	1349838	usd
CY2023Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	367500	usd
CY2022Q4	us-gaap	Adjustment For Amortization AdjustmentForAmortization	367500	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1102500	usd
	us-gaap	Adjustment For Amortization AdjustmentForAmortization	1102500	usd
CY2023Q4	us-gaap	Operating Expenses OperatingExpenses	2351293	usd
CY2022Q4	us-gaap	Operating Expenses OperatingExpenses	3154478	usd
	us-gaap	Operating Expenses OperatingExpenses	8176090	usd
	us-gaap	Operating Expenses OperatingExpenses	8795369	usd
CY2023Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-2273344	usd
CY2022Q4	us-gaap	Operating Income Loss OperatingIncomeLoss	-3056535	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7935000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8609365	usd
CY2022Q4	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	843494	usd
	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	5019883	usd
CY2022Q4	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	17738000	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
CY2023Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	67050	usd
CY2022Q4	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	1155000	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	337050	usd
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	3031000	usd
CY2023Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-3180000	usd
CY2022Q4	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-1594515	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-2512366	usd
	us-gaap	Gains Losses On Restructuring Of Debt GainsLossesOnRestructuringOfDebt	-1594515	usd
CY2022Q4	us-gaap	Loss From Catastrophes LossFromCatastrophes	6262	usd
	us-gaap	Loss From Catastrophes LossFromCatastrophes	869379	usd
CY2022Q4	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	2383088	usd
CY2023Q4	SHMP	Extension Fee ExtensionFee	-10000	usd
	SHMP	Extension Fee ExtensionFee	-190000	usd
CY2023Q4	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	22013	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	22013	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	16014	usd
CY2023Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3128720	usd
CY2022Q4	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	18232236	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2412034	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-2943455	usd
CY2023Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5402064	usd
CY2022Q4	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15175701	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-10347034	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-11552820	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-5402064	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	15175701	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10347034	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11552820	usd
CY2022Q4	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-28048	usd
	SHMP	Amortization Of Beneficial Conversion Feature On Preferred Shares AmortizationOfBeneficialConversionFeatureOnPreferredShares	-212048	usd
CY2023Q4	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	9300	usd
CY2022Q4	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	198333	usd
	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	9300	usd
	SHMP	Accretion On Preferred Shares AccretionOnPreferredShares	755333	usd
CY2023Q4	us-gaap	Dividends Dividends	59616	usd
CY2022Q4	us-gaap	Dividends Dividends	60107	usd
	us-gaap	Dividends Dividends	464441	usd
	us-gaap	Dividends Dividends	481761	usd
CY2023Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5470980	usd
CY2022Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	14889213	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10820775	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13001961	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.02
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.01
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.01
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.02
CY2023Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	938229589	shares
CY2022Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	697586776	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	885304007	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	682750957	shares
CY2023Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	938229589	shares
CY2022Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1629304739	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	885304007	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	682750957	shares
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-45689165	usd
CY2023Q2	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	1298512	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	477175	usd
CY2023Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	54000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	4700	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2298431	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-46261209	usd
CY2023Q3	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	456359	usd
CY2023Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	59616	usd
CY2023Q3	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	9300	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2646539	usd
CY2023Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-48520305	usd
CY2023Q4	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	568419	usd
CY2023Q4	SHMP	Shares Issued Upon Exchange Of Partitioned Note SharesIssuedUponExchangeOfPartitionedNote	160000	usd
CY2023Q4	SHMP	Common Stock Issued To Employees Amount CommonStockIssuedToEmployeesAmount	1100	usd
CY2023Q4	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	600000	usd
CY2023Q4	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	59616	usd
CY2023Q4	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	9300	usd
CY2023Q4	SHMP	Preferred Stock Accretion Of Series G Preferred Shares PreferredStockAccretionOfSeriesGPreferredShares	3000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-5402064	usd
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-52664766	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-33133765	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	840000	usd
CY2022Q2	SHMP	Amortization Of Beneficial Conversion Feature Related To Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToPreferredShares	-42500	usd
CY2022Q2	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	278500	usd
CY2022Q2	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	102227	usd
CY2022Q2	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2200176	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-34892793	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	720000	usd
CY2022Q3	SHMP	Increase In Preferred Shares To One Holder Based On Certain Rights IncreaseInPreferredSharesToOneHolderBasedOnCertainRights	-156000	usd
CY2022Q3	SHMP	Amortization Of Beneficial Conversion Feature Related To Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToPreferredShares	-42500	usd
CY2022Q3	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	278500	usd
CY2022Q3	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	55427	usd
CY2022Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	26000	usd
CY2022Q3	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-24528345	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-59183191	usd
CY2022Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-59183191	usd
CY2022Q4	SHMP	Issuance Of Common Shares Under Financing Agreement IssuanceOfCommonSharesUnderFinancingAgreement	1380000	usd
CY2022Q4	SHMP	Amortization Of Beneficial Conversion Feature Related To Preferred Shares AmortizationOfBeneficialConversionFeatureRelatedToPreferredShares	-28048	usd
CY2022Q4	us-gaap	Preferred Stock Accretion Of Redemption Discount PreferredStockAccretionOfRedemptionDiscount	198333	usd
CY2022Q4	us-gaap	Dividends Preferred Stock Stock DividendsPreferredStockStock	60107	usd
CY2022Q4	SHMP	Common Stock Vested To Consultants CommonStockVestedToConsultants	24375	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	15175701	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	15175701	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-42889603	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-42889603	usd
	us-gaap	Net Income Loss NetIncomeLoss	-10347034	usd
	us-gaap	Net Income Loss NetIncomeLoss	-11552820	usd
	SHMP	Depreciation Expense DepreciationExpense	1304732	usd
	SHMP	Depreciation Expense DepreciationExpense	1349838	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1102500	usd
	us-gaap	Cost Of Goods And Services Sold Amortization CostOfGoodsAndServicesSoldAmortization	1102500	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5019883	usd
	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	811000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-337050	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3031000	usd
	SHMP	Change In Fair Value Of Restructured Notes Payable ChangeInFairValueOfRestructuredNotesPayable	2512366	usd
	SHMP	Change In Fair Value Of Restructured Notes Payable ChangeInFairValueOfRestructuredNotesPayable	1594515	usd
	SHMP	Extension Fees ExtensionFees	-125000	usd
	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	28000	usd
	SHMP	Gain On Extinguishment Of Debt GainOnExtinguishmentOfDebt	1883089	usd
	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	16014	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	605800	usd
	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	99124	usd
	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	194849	usd
	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	22013	usd
	SHMP	Loss Due To Fire LossDueToFire	-869379	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1004	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-6883	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	12944	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	32759	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-43961	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-1021406	usd
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	-1336263	usd
	us-gaap	Increase Decrease In Deferred Policy Acquisition Costs IncreaseDecreaseInDeferredPolicyAcquisitionCosts	126963	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	169244	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	724360	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-19715	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	92560	usd
	SHMP	Increase Decrease In Accrued Expenses Related Parties IncreaseDecreaseInAccruedExpensesRelatedParties	523898	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	80637	usd
	us-gaap	Increase Decrease In Interest Payable Net IncreaseDecreaseInInterestPayableNet	1662647	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	25301	usd
	us-gaap	Increase Decrease In Due To Related Parties IncreaseDecreaseInDueToRelatedParties	9772	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	25000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-181586	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2857801	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3884764	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	67640	usd
	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	2430186	usd
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	59000	usd
	us-gaap	Proceeds From Sale Of Machinery And Equipment ProceedsFromSaleOfMachineryAndEquipment	700000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8640	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1730186	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	24000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	72000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	226	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2323291	usd
	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1380000	usd
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	1465000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	140000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	250000	usd
	SHMP	Proceeds From Convertible Debentures Receipt ProceedsFromConvertibleDebenturesReceipt	1500000	usd
	SHMP	Escrow Account In Relation To The Proceeds From Convertible Debenture EscrowAccountInRelationToTheProceedsFromConvertibleDebenture	-500000	usd
	SHMP	Proceeds From Sale Of Preferred Stock ProceedsFromSaleOfPreferredStock	150000	usd
	SHMP	Proceeds From Sale Of Preferred Stock Series G ProceedsFromSaleOfPreferredStockSeriesG	97000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2686291	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4022774	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-180150	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1592176	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	216465	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1734040	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	36315	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141864	usd
	us-gaap	Interest Paid Net InterestPaidNet	616	usd
	us-gaap	Interest Paid Net InterestPaidNet	1829570	usd
	SHMP	Construction In Process Transferred To Fixed Assets ConstructionInProcessTransferredToFixedAssets	1041371	usd
	us-gaap	Stock Issued1 StockIssued1	828000	usd
	us-gaap	Stock Issued1 StockIssued1	1560000	usd
	SHMP	Dividends On Series E Preferred Stock DividendsOnSeriesEPreferredStock	524057	usd
	us-gaap	Dividends Preferred Stock Paidinkind DividendsPreferredStockPaidinkind	516000	usd
	SHMP	Shares Issuedto Be Issued For Legal Settlement SharesIssuedtoBeIssuedForLegalSettlement	272743	usd
	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80F_eus-gaap--NatureOfOperations_z1TxmMImW9ta" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82D_zjIw3iGEMMv">NATURE OF THE ORGANIZATION AND BUSINESS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Nature of the Business</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">NaturalShrimp Incorporated (“NaturalShrimp” or the “Company”), a Nevada corporation, is a biotechnology company and has developed a proprietary technology that allows it to grow Pacific White shrimp (Litopenaeus vannamei, formerly Penaeus vannamei) in an ecologically controlled, high-density, low-cost environment, and in fully contained and independent production facilities. The Company’s system uses technology which allows it to produce a naturally-grown shrimp “crop” weekly and accomplishes this without the use of antibiotics or toxic chemicals. The Company has developed several proprietary technology assets, including a knowledge base that allows it to produce commercial quantities of shrimp in a closed system with a computer monitoring system that automates, monitors and maintains proper levels of oxygen, salinity and temperature for optimal shrimp production. The Company’s production facilities are located in La Coste, Texas and Webster City, Iowa.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has three wholly-owned subsidiaries including NaturalShrimp USA Corporation (“NSC”) and NaturalShrimp Global, Inc. (“NS Global”) and Natural Aquatic Systems, Inc. (“NAS”), and owns 51% of NaturalShrimp/Hydrenesis LLC, a Texas limited liability company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Going Concern</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accompanying condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”), assuming the Company will continue as a going concern, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. For the nine months ended December 31, 2023, the Company had a net loss available for common stockholders of approximately $<span id="xdx_900_eus-gaap--NetIncomeLossAvailableToCommonStockholdersBasic_iN_pn3p0_di_c20230401__20231231_ze2Y4TieG6z1" title="Net loss from operation">10,821,000</span>. As of December 31, 2023, the Company had an accumulated deficit of approximately $<span id="xdx_901_eus-gaap--RetainedEarningsAccumulatedDeficit_iNI_pn3p0_di_c20231231_zI5Hax6bLR5g" title="Accumulated deficit">178,426,000</span> and a working capital deficit of approximately $<span id="xdx_90A_ecustom--WorkingCapitalDeficit_iNI_di_c20231231_zFbR7anN3MUa" title="Working capital deficit">10,406,000</span>. These factors raise substantial doubt about the Company’s ability to continue as a going concern, within one year from the issuance date of this filing. The Company’s ability to continue as a going concern is dependent on its ability to raise the required additional capital or debt financing to meet short and long-term operating requirements. During the nine months ended December 31, 2023, the Company received net cash proceeds of approximately $<span id="xdx_909_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20230401__20231231_zSbAJvFp22S2" title="Sale of stock consideration">2,323,000</span> from the sale of common shares (See Note 8), $<span id="xdx_904_ecustom--ProceedsFromSaleOfPreferredStock_c20230401__20231231_zeIsWfV1CmDf" title="Proceeds from sale of Series E Preferred Shares">150,000</span> from the sale of Series E Preferred stock, $<span id="xdx_908_ecustom--ProceedsFromSaleOfPreferredStockSeriesG_c20230401__20231231_zxMzODgZ4nnc" title="Proceeds from sale of Series G Preferred Shares">97,000</span> from the sale of Series G Preferred stock and the Company received $<span id="xdx_90D_eus-gaap--ProceedsFromRelatedPartyDebt_c20230401__20231231_zXESVM7H4mhd" title="Proceeds from issuance of promissory notes, related parties">140,000</span> proceeds from the issuance of promissory notes, related parties. Subsequent to period end, the Company received approximately $<span id="xdx_905_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20240101__20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zZUY8HaKHsN6" title="Sale of stock consideration">248,000</span> for the sale of common shares and $<span id="xdx_909_ecustom--ProceedsFromSaleOfPreferredStockSeriesG_c20240101__20240131__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zo6dbdvd8jOi" title="Proceeds from sale of Series G Preferred Shares">97,000</span> from the sale of Series G Preferred stock (See Note 12).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management believes that private placements of equity capital will be needed to fund the Company’s long-term operating requirements. The Company may also encounter business endeavors that require significant cash commitments or unanticipated problems or expenses that could result in a requirement for additional cash. If the Company raises additional funds through the issuance of equity, the percentage ownership of its current shareholders could be reduced, and such securities might have rights, preferences or privileges senior to its common stock. Additional financing may not be available upon acceptable terms, or at all. If adequate funds are not available or are not available on acceptable terms, the Company may not be able to take advantage of prospective business endeavors or opportunities, which could significantly and materially restrict its operations. The Company continues to pursue external financing alternatives to improve its working capital position. If the Company is unable to obtain the necessary capital, the Company may be unable to develop its facilities and enter into production.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p>
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10821000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-178426000	usd
CY2023Q4	SHMP	Working Capital Deficit WorkingCapitalDeficit	-10406000	usd
	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	2323000	usd
	SHMP	Proceeds From Sale Of Preferred Stock ProceedsFromSaleOfPreferredStock	150000	usd
	SHMP	Proceeds From Sale Of Preferred Stock Series G ProceedsFromSaleOfPreferredStockSeriesG	97000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	140000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84F_eus-gaap--UseOfEstimates_z14bVRR9plil" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_861_zNIGRR8qKJWi">Use of Estimates</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preparing financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	355000	usd
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3923000	usd
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-337050	usd
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3568000	usd
CY2023Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	17950	usd
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	355000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	23690000	usd
	SHMP	Reclass Of Accrued Interest ReclassOfAccruedInterest	907634	usd
CY2023	SHMP	Fair Value Of Promissory Note Upon Restructuring Agreement FairValueOfPromissoryNoteUponRestructuringAgreement	20847867	usd
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2512366	usd
CY2023	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	2842133	usd
CY2023Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	27110000	usd
CY2023Q1	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	23690000	usd
CY2022Q4	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The fair value for both periods is based on the maturity dates, the interest of 12%, the 15% exit fee, the 2% appreciation fee for an estimated period, and a 45% and 40% present value factor
CY2022Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.12	pure
CY2022Q4	SHMP	Debt Instrument Exit Fee Percentage DebtInstrumentExitFeePercentage	0.15	pure
CY2023Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	101302	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	97943	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	365184	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	186004	usd
CY2023Q2	SHMP	Service Fee ServiceFee	25000	usd
	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	250000	usd
	SHMP	Monthly Service Fees MonthlyServiceFees	100000	usd
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
CY2023Q1	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_849_eus-gaap--ConcentrationRiskCreditRisk_zgHO8XNqc8F4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i><span id="xdx_862_zOqZt8wlQd8d">Concentration of Credit Risk</span></i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company maintains cash balances at two financial institutions. Accounts at this institution are insured by the Federal Deposit Insurance Corporation (“FDIC”) up to $<span id="xdx_903_eus-gaap--CashFDICInsuredAmount_iI_c20231231_z2lHt5t2m7df" title="Cash, FDIC insured amount">250,000</span>. As of December 31, 2023 and March 31, 2023, the Company’s cash balance exceeded FDIC coverage. The Company has not experienced any losses in such accounts and periodically evaluates the credit worthiness of the financial institutions and has determined the credit exposure to be negligible.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000	usd
CY2023Q4	us-gaap	Land Land	324293	usd
CY2023Q1	us-gaap	Land Land	324293	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5528758	usd
CY2023Q1	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	5495150	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12306776	usd
CY2023Q1	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	12293112	usd
CY2023Q4	SHMP	Automobiles Gross AutomobilesGross	260043	usd
CY2023Q1	SHMP	Automobiles Gross AutomobilesGross	307227	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18419870	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	18419782	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	4656233	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3376067	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13763637	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	15043715	usd
CY2023Q4	us-gaap	Depreciation Depreciation	433000	usd
CY2022Q4	us-gaap	Depreciation Depreciation	416000	usd
	us-gaap	Depreciation Depreciation	1305000	usd
	us-gaap	Depreciation Depreciation	1350000	usd
	SHMP	Description For Uplisted Term And Trigger Events DescriptionForUplistedTermAndTriggerEvents	In conjunction with the Merger Agreement, entered into on October 24, 2022, with Yotta Acquisition Corporation (Note 11), on November 4, 2022, the Company entered into a Restructuring Agreement for an Amended and Restated Secured Promissory Note (the “August Note”), through which the August Note was amended and restated in its entirety. The Restructured August Note decreased the principal to $1,748,667, less an OID of $138,667, and the amount in escrow was returned to the investor, The Restructuring Agreement included key modifications, in which i) the Uplist terms were removed, ii) in the event that the closing of the Merger does not occur on or before December 31, 2022, the then-current Outstanding Balance will be increased by 2% and shall increase by 2% every 30 days thereafter until the closing or termination of the Merger Agreement, and iii) the outstanding balance of the Convertible Note may be increased by 5% to 15% upon the occurrence of an event of default or failure to obtain the Lender’s consent or notify the Lender for certain major equity related transactions (“Trigger Events”).
CY2023Q4	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2024-06-30
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	1400000000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2016Q1	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.02	pure
CY2023Q4	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
CY2023Q1	us-gaap	Accounts Payable Current And Noncurrent AccountsPayableCurrentAndNoncurrent	146000	usd
	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.08	pure
CY2023Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	54647	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	7000	usd
CY2021Q3	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
	us-gaap	Operating Lease Payments OperatingLeasePayments	1727	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-10-31
CY2021Q2	us-gaap	Deposits Deposits	52362	usd
CY2021Q2	us-gaap	Security Deposit SecurityDeposit	17454	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	316000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	316000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
CY2023Q4	us-gaap	Lessor Operating Lease Description LessorOperatingLeaseDescription	The monthly rates are $2,063 for April 1, 2024 through March 31, 2025, $2,192 for the second year of April 1, 2025 through March 31, 2026 and $2,320 for the final year.
CY2023Q4	us-gaap	Security Deposit SecurityDeposit	2063	usd
CY2021Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	300	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	17000	usd
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	17000	usd
CY2021Q3	SHMP	Operating Leases Borrowing Rate OperatingLeasesBorrowingRate	0.0575	pure
	us-gaap	Professional Fees ProfessionalFees	1394366	usd

Files In Submission

Name	View Source	Status
0001493152-24-006697-index-headers.html	Edgar Link	pending
0001493152-24-006697-index.html	Edgar Link	pending
0001493152-24-006697.txt	Edgar Link	pending
0001493152-24-006697-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
shmp-20231231.xsd	Edgar Link	pending
form10-q_htm.xml	Edgar Link	completed
Show.js	Edgar Link	pending
shmp-20231231_cal.xml	Edgar Link	unprocessable
shmp-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
shmp-20231231_def.xml	Edgar Link	unprocessable
shmp-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$SHMP
NaturalShrimp Inc Stock $shmp

2024 Q1 Form 10-Q Financial Statement

#000149315224006697 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP NaturalShrimp Inc Stock $shmp

2024 Q1 Form 10-Q Financial Statement

#000149315224006697 Filed on February 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$SHMP
NaturalShrimp Inc Stock $shmp